Zhou H, Ji L, Song X et al (2024) ZT002, a novel ultra long-acting GLP-1 receptor agonist in adults with overweight or obesity: a randomised, placebo-controlled, multiple ascending dose phase 1c study
In DAPA-CKD, among 4,304 participants (67.5% with type 2 diabetes mellitus and 15.3% with prediabetes at baseline), the mean eGFR was 43.1 mL/min/1.73 m and the median UACR was 949 mg/g [47,52]
No batch drift
Severely restricting your calories on Mounjaro can lead to muscle loss, nutritional deficiencies, and extreme fatigue
When should I contact my GP about sulphur burps whilst taking GLP-1 medication
The GLP-1 market has been periodically hampered by shortages, and Lilly is betting that putting the drug into this new form will allow them to produce a more robust supply